Home Authors Posts by Winway Health Desk

Winway Health Desk

1472 POSTS 0 COMMENTS

FDA Approves Herzuma (trastuzumab-pkrb), a Biosimilar to Herceptin

FDA Approves Herzuma (trastuzumab-pkrb), a Biosimilar to Herceptin INCHEON, South Korea & JERUSALEM--(BUSINESS WIRE) December 14, 2018 --Celltrion, Inc. and Teva Pharmaceutical Industries Ltd. today...

Stride Health is making health coverage easier for the gig economy

As the Affordable Care Act open enrollment period for 2019 draws to a close, a number of factors have conspired to create what projects...

Emulating start-up success with purpose-built data tools

Posted on December 12th, 2018 by admin in Pharma R&D...

PHOTO TOUR: Michael E. DeBakey VA Medical Center Building

The Michael E. DeBakey VA Medical Center building in Houston comprises a vertical expansion and renovation to house the relocated Mental Health Clinic Trauma...

FiercePharmaAsia—Possible Sun probe; Huahai warning letter; Eisai-UCL neuro pact

The possibility of a government investigation looms ever larger for Sun Pharma, as Indian regulators said they're indeed reviewing whistleblower allegations against the company....

Planning Healthcare Interiors Through Journey Mapping

Journey mapping has grown in popularity in healthcare planning because it can serve as a versatile tool to understand how and what provokes emotions...

Type 2 diabetes and memory loss investigated in older people

Type 2 diabetes in older people can lead to increased memory loss and verbal fluency, but this is not directly associated with...

J&J stock tumbles after Reuters reports it hid asbestos in talc

After a series of ups and downs in defense of its flagship Johnson’s Baby Powder, Johnson & Johnson hit renewed scrutiny Friday as Reuters...

Former athenahealth CEO slams Elliott Management in CNBC interview

In an interview on CNBC’s “Squawk on the Street” earlier this week, former athenahealth CEO Jonathan Bush criticized Elliott Management, the activist investor that took...

FDA issues warning over biosimilars availability block

The US Food and Drug Administration (FDA) has warned companies that attempt to block cheaper biosimilar alternatives from being made available in...
0FansLike
65,684FollowersFollow
20,402SubscribersSubscribe

EDITOR PICKS